IOL Chemicals & Pharmaceuticals posted record Q1FY27 performance, with PAT rising 90% to Rs.64.05 cr. Non-Ibuprofen products contributed 43% of pharma revenue, while chemicals revenue and EBIT grew 29% and 193% YoY, respectively. Stock may surpass its 52-week high of Rs.180.









